解脲支原体致病性与治疗决策  

Pathogenicity and Therapeutic Decision-making of Ureaplasma Urealyticum

作　　者：刘淑荣[1] 张洪文[1] 

机构地区：[1]中南大学湘雅二医院妇产科,湖南长沙410011

出　　处：《医学与哲学（B）》2009年第10期6-8,共3页Medicine & Philosophy(B)

摘　　要：解脲支原体,是女性泌尿生殖道常见的一种介于细胞和病毒之间的微生物,可以通过性接触传播,在一定的条件下可以成为致病病原体。由于对其致病性认识不清,临床上对宫颈分泌物解脲支原体检测阳性的女性,存在不规范大剂量滥用抗生素,导致其耐药性日趋严重,因此对解脲支原体致病性和治疗的研究已成为目前研究的热点。现简要讨论其生物学特性、致病性与治疗。Ureaplasma urealyticum（Uu） which mainly exists in female urogenital tract is a common microorganisms between cells and virus that can be transmitted through sexual contact. Under certain conditions it can become pathogenic pathogens. Because of its inadequate understanding of the pathogenicity , clinical detection of cervical secretions Uu--positive women and the existence of nonstandard high dose abuse of antibiotics have led to increasingly serious Uu--resistant traits, so the pathogenicity of Uu and therapy research has become a research hotspot. This article discussed the biology characteristics, pathogenicity and its therapy.

关 键 词：解脲支原体 致病 治疗 

分 类 号：R711.31[医药卫生—妇产科学]